Equities

Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,272.20
  • Today's Change9.20 / 0.73%
  • Shares traded168.06k
  • 1 Year change+1.78%
  • Beta0.8028
Data delayed at least 15 minutes, as of Nov 22 2024 10:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy2
Outperform5
Hold0
Sell1
Strong Sell1

Share price forecast in INR

The 9 analysts offering 12 month price targets for Narayana Hrudayalaya Ltd have a median target of 1,408.00, with a high estimate of 1,650.00 and a low estimate of 1,030.00. The median estimate represents a 11.48% increase from the last price of 1,263.00.
High30.6%1,650.00
Med11.5%1,408.00
Low-18.4%1,030.00

Dividends

In 2024, Narayana Hrudayalaya Ltd reported a dividend of 4.00 INR. The 3 analysts covering the company expect dividends of 3.20 INR for the upcoming fiscal year, a decrease of 20.00%.
Div growth (TTM)--
More ▼

Earnings history & estimates in INR

On Oct 31, 2024, Narayana Hrudayalaya Ltd reported 2nd quarter 2025 earnings of 9.78 per share. This result was in line with the consensus of the 2 analysts following the company and under-performed last year's 2nd quarter results by 12.37%.
The next earnings announcement is expected on Feb 12, 2025.
Average growth rate-2.85%
Narayana Hrudayalaya Ltd reported annual 2024 earnings of 38.86 per share on May 24, 2024.
Average growth rate+53.72%
More ▼

Revenue history & estimates in INR

Narayana Hrudayalaya Limited had 2nd quarter 2025 revenues of 14.00bn. This missed the 14.26bn consensus estimate of the 6 analysts following the company. This was 13.51% above the prior year's 2nd quarter results.
Average growth rate+1.93%
Narayana Hrudayalaya Limited had revenues for the full year 2024 of 50.18bn. This was 10.91% above the prior year's results.
Average growth rate+14.76%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.